Page last updated: 2024-11-05

thalidomide and Acrania

thalidomide has been researched along with Acrania in 2 studies

Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cutting, R1
Dalley, C1
Ezaydi, Y1
Winfield, D1
Snowden, JA1
Michejda, M1
Hodgen, GD1

Other Studies

2 other studies available for thalidomide and Acrania

ArticleYear
Lessons from a Jehovah's Witness with 5q- syndrome: role of systemic immunosuppression and kinetics of recovery with lenalidomide from a life threatening anaemia.
    British journal of haematology, 2008, Volume: 142, Issue:3

    Topics: Antineoplastic Agents; Female; Gene Deletion; Humans; Immunosuppression Therapy; Jehovah's Witnesses

2008
Induction of neural-tube defects in nonhuman primates.
    Progress in clinical and biological research, 1985, Volume: 163B

    Topics: Abnormalities, Drug-Induced; alpha-Fetoproteins; Animals; Female; Macaca mulatta; Neural Tube Defect

1985